ArticleAmerican journal of preventive medicine2016
Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Article in American journal of preventive medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Adolescent and young adult cancer survivor experiences of financial toxicity: a scoping review.Journal of cancer survivorship : research and practice · 2026Review
- Ensemble machine learning for predicting costs and cost influencers in breast cancer surgery.BMC health services research · 2025Article
- Global, Regional, and National Burden of Breast Cancer in Adolescents and Young Adults Aged 15-39 Years From 1990 to 2021 Based on the Global Burden of Disease Study 2021.Cancer innovation · 2025Article
- Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.Annals of surgical oncology · 2025Article
- Context-Specific Estimation of Future Unrelated Medical Costs and Their Impact on Cost-Effectiveness Analyses.PharmacoEconomics · 2023Article
- Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.Breast cancer (Tokyo, Japan) · 2023Article
- Cost-Related Access Barriers, Medical Debt, and Dissatisfaction with Care Among Privately Insured Americans.Journal of general internal medicine · 2023Article
- Effects of Breast-Conserving Surgery Combined with Immediate Autologous Fat Grafting on Oncologic Safety, Satisfaction and Psychology in Patients with Breast Cancer: A Retrospective Cohort Study.Cancer management and research · 2022Article
- Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030.JNCI cancer spectrum · 2021Article
- Cost analysis of breast cancer: a comparison between private and public hospitals in Iran.BMC health services research · 2021Article
- Medical costs associated with metastatic breast cancer in younger, midlife, and older women.Breast cancer research and treatment · 2020Article
- Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach.European journal of breast health · 2019Article
- Article
- Observational
- Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013.Breast cancer research and treatment · 2018Article
- Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.Breast cancer research and treatment · 2017Article
- Breast cancer treatment costs in younger, privately insured women.Breast cancer research and treatment · 2017Article
- The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future.American journal of preventive medicine · 2016Article
- Health Care Expenditure Burden of Cancer Care in the United States.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
introductionBreast cancer in women aged 18-44 years accounts for approximately 27,000 newly diagnosed cases and 3,000 deaths annually. When tumors are diagnosed, they are usually aggressive, resulting in expensive treatment costs. The purpose of this study is to estimate the prevalent medical costs attributable to breast cancer treatment among privately insured younger women.
methodsData from the 2006 MarketScan database representing claims for privately insured younger women were used. Costs for younger breast cancer patients were compared with a matched sample of younger women without breast cancer, overall and for an active treatment subsample. Analyses were conducted in 2013 with medical care costs expressed in 2012 U.S. dollars.
resultsYounger women with breast cancer incurred an estimated $19,435 (SE=$415) in additional direct medical care costs per person per year compared with younger women without breast cancer. Outpatient expenditures comprised 94% of the total estimated costs ($18,344 [SE=$396]). Inpatient costs were $43 (SE=$10) higher and prescription drug costs were $1,048 (SE=$64) higher for younger women with breast cancer than in younger women without breast cancer. For women in active treatment, the burden was more than twice as high ($52,542 [SE=$977]).
conclusionsThese estimates suggest that breast cancer is a costly illness to treat among younger, privately insured women. This underscores the potential financial vulnerability of women in this age group and the importance of health insurance during this time in life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.